Glaukos Corp(GKOS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GKOS Glaukos Corp

休市中 04-04 16:00:00 EDT

83.65

-3.35

-3.85%

盘后83.65

+0.000.00%

19:53 EDT

最高85.47	最低77.91	成交量171.58万
今开83.09	昨收87.00	日振幅8.69%
总市值47.30亿	流通市值45.75亿	总股本5,654万
成交额1.43亿	换手率3.14%	流通股本5,469万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GKOS","market":"US","secType":"STK","nameCN":"Glaukos Corp","latestPrice":83.65,"timestamp":1743796800000,"preClose":87,"halted":0,"volume":1715781,"hourTrading":{"tag":"盘后","latestPrice":83.65,"preClose":83.65,"latestTime":"19:53 EDT","volume":1217,"amount":101677.44,"timestamp":1743810782899},"delay":0,"floatShares":54688444,"shares":56539386,"eps":-2.774561,"marketStatus":"休市中","change":-3.35,"latestTime":"04-04 16:00:00 EDT","open":83.09,"high":85.47,"low":77.91,"amount":142574572.29162,"amplitude":0.086897,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-2.774561,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1744012800000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1435204800000,"exchange":"NYSE","adjPreClose":87,"preHourTrading":{"tag":"盘前","latestPrice":82.06,"preClose":87,"latestTime":"09:16 EDT","volume":37,"amount":3125.49989,"timestamp":1743772562036},"postHourTrading":{"tag":"盘后","latestPrice":83.65,"preClose":83.65,"latestTime":"19:53 EDT","volume":1217,"amount":101677.44,"timestamp":1743810782899},"volumeRatio":1.5882931558692237,"impliedVol":0.9907,"impliedVolPercentile":0.996},"requestUrl":"/m/hq/s/GKOS","defaultTab":"news","newsList":[{"id":"2518322289","title":"Glaukos Corporation跌4.08% 股价跌破100美元大关","url":"https://stock-news.laohu8.com/highlight/detail?id=2518322289","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2518322289?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:32","pubTimestamp":1741613579,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时32分，Glaukos Corporation股票出现波动，股价急速跳水4.08%。截至发稿，该股报99.94美元/股，成交量8598股，换手率0.02%，振幅1.40%。Glaukos Corporation股票所在的医疗器械行业中，整体跌幅为0.62%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科制药和医疗技术公司，专注于开发用于青光眼、角膜疾病和视网膜疾病治疗的新型、无滴疗法和商业化相关产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213300a26a2520&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250310213300a26a2520&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","GKOS","LU2065731478.USD","BK4082","LU1878469433.USD","IE0009354923.USD"],"gpt_icon":0},{"id":"2517319455","title":"Glaukos Corporation盘中异动 下午盘急速下跌5.14%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517319455","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2517319455?lang=zh_cn&edition=full","pubTime":"2025-03-07 02:26","pubTimestamp":1741285610,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日02时26分，Glaukos Corporation股票出现波动，股价快速跳水5.14%。截至发稿，该股报106.36美元/股，成交量29.6086万股，换手率0.52%，振幅3.26%。Glaukos Corporation股票所在的医疗器械行业中，整体跌幅为2.00%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科制药和医疗技术公司，专注于开发用于青光眼、角膜疾病和视网膜疾病治疗的新型、无滴疗法和商业化相关产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307022651963c7667&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307022651963c7667&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","IE0009354923.USD","BK4548","BK4082","GKOS","LU2065731478.USD"],"gpt_icon":0},{"id":"2516373576","title":"Glaukos Corporation盘中异动 早盘急速下跌5.18%报113.80美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516373576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2516373576?lang=zh_cn&edition=full","pubTime":"2025-03-03 23:05","pubTimestamp":1741014342,"startTime":"0","endTime":"0","summary":"北京时间2025年03月03日23时05分，Glaukos Corporation股票出现波动，股价大幅下挫5.18%。截至发稿，该股报113.80美元/股，成交量10.7329万股，换手率0.19%，振幅4.82%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为0.59%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230542989a199d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250303230542989a199d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","GKOS","BK4082","LU1878469433.USD","IE0009354923.USD","LU2065731478.USD"],"gpt_icon":0},{"id":"2514015888","title":"Glaukos Corporation盘中异动 早盘股价大跌5.20%报117.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514015888","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2514015888?lang=zh_cn&edition=full","pubTime":"2025-02-25 23:11","pubTimestamp":1740496279,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日23时11分，Glaukos Corporation股票出现异动，股价急速下跌5.20%。截至发稿，该股报117.78美元/股，成交量19.1002万股，换手率0.34%，振幅5.88%。Glaukos Corporation股票所在的医疗器械行业中，整体跌幅为0.41%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。它提供iStent，一种微型旁路支架，可与白内障手术配合插入，以降低成年人轻度至中度开角型青光眼患者的眼内压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231120962ffbaa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225231120962ffbaa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GKOS","BK4082","IE0009354923.USD","LU2065731478.USD","BK4548","LU1878469433.USD"],"gpt_icon":0},{"id":"2513375613","title":"Glaukos Corporation2024财年实现净利润-1.46亿美元，同比减少8.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513375613","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513375613?lang=zh_cn&edition=full","pubTime":"2025-02-24 00:01","pubTimestamp":1740326467,"startTime":"0","endTime":"0","summary":"2月24日，Glaukos Corporation公布财报，公告显示公司2024财年净利润为-1.46亿美元，同比减少8.15%；其中营业收入为3.83亿美元，同比增加21.59%，每股基本收益为-2.77美元。从资产负债表来看，Glaukos Corporation总负债2.08亿美元，其中短期债务--，资产负债比为4.69，流动比率为0.06。机构评级：截至2025年2月24日，当前有13家机构对Glaukos Corporation目标价做出预测，其中目标均价为168.62美元，其中最低目标价为120.00美元，最高目标价为200.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000140abd9c7e4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000140abd9c7e4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GKOS"],"gpt_icon":0},{"id":"1174826046","title":"异动解读 | 医疗器械公司Glaukos第四季度亏损扩大 股价大跌13.2%","url":"https://stock-news.laohu8.com/highlight/detail?id=1174826046","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1174826046?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:37","pubTimestamp":1740148650,"startTime":"0","endTime":"0","summary":"医疗技术公司Glaukos(GKOS)今日盘中大跌13.2%,引发市场广泛关注。\n\n该公司昨日公布了2024年第四季度财报,数据显示当季净亏损达到2220万美元,大幅超出市场预期的2080万美元亏损。尽管营收达到1.055亿美元高于预期,但亏损扩大的情况仍令投资者信心受挫。\n\n值得一提的是,Glaukos的主要产品iStent inject W是一种用于治疗青光眼的创新医疗器械,针对这种常见但损害视神经的眼病。公司的这一核心业务前景广阔,但本季度的财报业绩不佳或许给市场带来一些负面影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GKOS"],"gpt_icon":0},{"id":"2513296561","title":"Glaukos Corporation盘中异动 急速下挫12.32%报137.97美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513296561","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513296561?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:32","pubTimestamp":1740148334,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时32分，Glaukos Corporation股票出现波动，股价快速下挫12.32%。截至发稿，该股报137.97美元/股，成交量13.5999万股，换手率0.24%，振幅3.79%。Glaukos Corporation股票所在的医疗器械行业中，整体跌幅为0.36%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223214abd7afc4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223214abd7afc4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4082","LU2065731478.USD","LU1878469433.USD","IE0009354923.USD","GKOS"],"gpt_icon":0},{"id":"1126707519","title":"异动解读 | 医疗技术公司Glaukos第四季度亏损扩大,股价盘前大跌11.67%","url":"https://stock-news.laohu8.com/highlight/detail?id=1126707519","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1126707519?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:10","pubTimestamp":1740147030,"startTime":"0","endTime":"0","summary":"医疗技术公司Glaukos(GKOS)股价今日盘前大跌11.67%,引发市场广泛关注。\n\nGlaukos公司昨日发布了第四季度财报,数据显示该公司第四季度净亏损扩大至2220万美元,远超市场预期的2080万美元亏损。虽然营收达到1.055亿美元高于市场预期,但仍未能令投资者信心完全恢复。\n\n值得一提的是,Glaukos的主要产品iStent inject W是一种用于治疗青光眼的创新医疗器械,针对一种损害视神经的严重眼病。公司业务发展前景一直备受市场关注,但近期财务数据不佳或许给投资者带来一些负面影响。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GKOS"],"gpt_icon":0},{"id":"2513267826","title":"Needham：维持Glaukos(GKOS.US)评级，由买入调整至买入评级, 目标价由149.00美元调整至176.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513267826","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2513267826?lang=zh_cn&edition=full","pubTime":"2025-02-21 20:51","pubTimestamp":1740142319,"startTime":"0","endTime":"0","summary":"Needham：维持Glaukos(GKOS.US)评级，由买入调整至买入评级, 目标价由149.00美元调整至176.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/21205148319260.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GKOS"],"gpt_icon":0},{"id":"1151662734","title":"异动解读 | GKOS公司盘后大跌14.21%,财报亏损超预期或为主因","url":"https://stock-news.laohu8.com/highlight/detail?id=1151662734","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151662734?lang=zh_cn&edition=full","pubTime":"2025-02-21 05:32","pubTimestamp":1740087147,"startTime":"0","endTime":"0","summary":"眼科医疗器械公司GKOS(Glaukos Corp)股价于今日盘后大跌14.21%,引发市场广泛关注。\n\n分析认为,公司2024年第四季度财报表现可能是股价大跌的主要诱因。数据显示,GKOS上季度销售额达到1.055亿美元,同比增长28.09%,超出分析师预期。但公司每股亏损达到0.40美元,高于预期的0.38美元,这可能令投资者对公司增长前景产生担忧,加大抛售力度。\n\n不过,仅从财报数据看,14.21%的大跌幅度似乎过大,分析人士推测可能还存在其他市场暂未掌握的负面消息,共同导致股价重挫。GKOS当前盈利能力不济的状态是否将持续,以及公司未来能否重现增长,仍需进一步观察。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"异动解读 | GKOS公司盘后大跌14.21%,财报亏损超预期或为主因","news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["GKOS"],"gpt_icon":0},{"id":"1101933895","title":"Glaukos 2024年第四季度调整后EPS $(0.40) 不及$(0.38)预期，销售额$1.055亿超出$1.00491亿预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1101933895","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1101933895?lang=zh_cn&edition=full","pubTime":"2025-02-21 05:14","pubTimestamp":1740086089,"startTime":"0","endTime":"0","summary":"Glaukos 报告季度每股亏损$，未达到分析师一致预期的$，差距为5.26%。公司报告季度销售额为1.055亿美元，超出分析师一致预期的1.00491亿美元，超出幅度为4.98%。相比去年同期的8236.5万美元，此次销售额增长了28.09%。以上内容来自Benzinga Earnings专栏，原文如下：Glaukos  reported quarterly losses of $ per share which missed the analyst consensus estimate of $ by 5.26 percent. This is a 36.51 percent increase over losses of $ per share from the same period last year.  The company reported quarterly sales of $105.500 million which beat the analyst consensus estimate of $100.491 million by 4.98 percent.  ","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Glaukos 2024年第四季度调整后EPS $(0.40) 不及$(0.38)预期，销售额$1.055亿超出$1.00491亿预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GKOS"],"gpt_icon":0},{"id":"2512431009","title":"Glaukos Corporation盘中异动 股价大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512431009","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2512431009?lang=zh_cn&edition=full","pubTime":"2025-02-20 04:47","pubTimestamp":1739998065,"startTime":"0","endTime":"0","summary":"北京时间2025年02月20日04时47分，Glaukos Corporation股票出现波动，股价急速上涨5.04%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为0.73%。其相关个股中，Sintx Technologies, Inc.、Reshape Lifesciences, Inc.、沃氪医疗涨幅较大，Sintx Technologies, Inc.、Reshape Lifesciences, Inc.、Bone Biologics Corp较为活跃，换手率分别为5192.94%、1126.06%、44.61%，振幅较大的相关个股有Sintx Technologies, Inc.、Reshape Lifesciences, Inc.、Ainos Inc C/Wts 29/07/2027 ，振幅分别为65.96%、55.56%、40.58%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022004474596290886&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022004474596290886&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","BK4082","LU1878469433.USD","LU2065731478.USD","GKOS","IE0009354923.USD"],"gpt_icon":0},{"id":"2511661177","title":"Glaukos Corporation盘中异动 股价大涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511661177","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2511661177?lang=zh_cn&edition=full","pubTime":"2025-02-15 03:57","pubTimestamp":1739563079,"startTime":"0","endTime":"0","summary":"北京时间2025年02月15日03时57分，Glaukos Corporation股票出现异动，股价大幅上涨5.25%。截至发稿，该股报154.06美元/股，成交量35.5627万股，换手率0.64%，振幅4.52%。Glaukos Corporation股票所在的医疗器械行业中，整体跌幅为0.47%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215035800962362f9&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250215035800962362f9&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU1878469433.USD","LU2065731478.USD","GKOS","IE0009354923.USD","BK4082","BK4548"],"gpt_icon":0},{"id":"2506053113","title":"Piper Sandler：重申Glaukos(GKOS.US)评级，由增持调整至增持评级, 目标价由140.00美元调整至180.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2506053113","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2506053113?lang=zh_cn&edition=full","pubTime":"2025-01-27 22:51","pubTimestamp":1737989495,"startTime":"0","endTime":"0","summary":"Piper Sandler：重申Glaukos(GKOS.US)评级，由增持调整至增持评级, 目标价由140.00美元调整至180.00美元。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/01/27225147863791.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["GKOS"],"gpt_icon":0},{"id":"2504942501","title":"Glaukos Corporation盘中异动 股价大涨5.12%报157.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2504942501","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2504942501?lang=zh_cn&edition=full","pubTime":"2025-01-17 04:04","pubTimestamp":1737057874,"startTime":"0","endTime":"0","summary":"北京时间2025年01月17日04时04分，Glaukos Corporation股票出现波动，股价急速上涨5.12%。截至发稿，该股报157.44美元/股，成交量30.3678万股，换手率0.55%，振幅5.05%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为1.84%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。它提供iStent，一种微型旁路支架，可与白内障手术配合插入，以降低成年人轻度至中度开角型青光眼患者的眼内压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501170404349868cdb0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501170404349868cdb0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","BK4548","LU2065731478.USD","LU1878469433.USD","GKOS","IE0009354923.USD"],"gpt_icon":0},{"id":"2493479400","title":"Glaukos Corporation盘中异动 股价大涨5.00%报150.92美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2493479400","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2493479400?lang=zh_cn&edition=full","pubTime":"2024-12-21 04:54","pubTimestamp":1734728075,"startTime":"0","endTime":"0","summary":"北京时间2024年12月21日04时54分，Glaukos Corporation股票出现异动，股价大幅上涨5.00%。截至发稿，该股报150.92美元/股，成交量58.3864万股，换手率1.06%，振幅5.60%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为1.44%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221045436984d00b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241221045436984d00b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","IE0009354923.USD","GKOS","BK4082","LU1878469433.USD"],"gpt_icon":0},{"id":"2490639648","title":"Glaukos Corporation盘中异动 早盘快速上涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2490639648","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2490639648?lang=zh_cn&edition=full","pubTime":"2024-12-11 22:35","pubTimestamp":1733927707,"startTime":"0","endTime":"0","summary":"北京时间2024年12月11日22时35分，Glaukos Corporation股票出现波动，股价快速拉升5.25%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为0.25%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。它提供iStent，一种微型旁路支架，可与白内障手术配合插入，以降低成年人轻度至中度开角型青光眼患者的眼内压。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223508a1e66c79&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241211223508a1e66c79&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GKOS","BK4548","LU1878469433.USD","IE0009354923.USD","BK4082"],"gpt_icon":0},{"id":"2489258333","title":"Glaukos Corporation盘中异动 早盘股价大涨5.03%报142.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2489258333","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2489258333?lang=zh_cn&edition=full","pubTime":"2024-12-07 00:18","pubTimestamp":1733501918,"startTime":"0","endTime":"0","summary":"北京时间2024年12月07日00时18分，Glaukos Corporation股票出现波动，股价急速上涨5.03%。截至发稿，该股报142.52美元/股，成交量14.2367万股，换手率0.26%，振幅3.80%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为0.73%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241207001839a1d9a421&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241207001839a1d9a421&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","LU1878469433.USD","GKOS","BK4548","IE0009354923.USD"],"gpt_icon":0},{"id":"2484795971","title":"Glaukos Corporation盘中异动 大幅拉升5.16%报144.05美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2484795971","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2484795971?lang=zh_cn&edition=full","pubTime":"2024-11-20 02:52","pubTimestamp":1732042341,"startTime":"0","endTime":"0","summary":"北京时间2024年11月20日02时52分，Glaukos Corporation股票出现异动，股价快速拉升5.16%。截至发稿，该股报144.05美元/股，成交量15.7891万股，换手率0.29%，振幅5.84%。Glaukos Corporation股票所在的医疗器械行业中，整体涨幅为0.24%。Glaukos Corporation公司简介：Glaukos Corp是一家眼科医疗技术公司，从事开发和商业化用于治疗青光眼的产品和程序。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120025221abcfdcbc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241120025221abcfdcbc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4548","GKOS","LU1878469433.USD","IE0009354923.USD","BK4082"],"gpt_icon":0},{"id":"2482427154","title":"Glaukos Corporation2024财年第三财季实现净利润-21.41百万美元，同比增加29.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2482427154","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2482427154?lang=zh_cn&edition=full","pubTime":"2024-11-10 00:03","pubTimestamp":1731168210,"startTime":"0","endTime":"0","summary":"11月10日，Glaukos Corporation公布财报，公告显示公司2024财年第三财季净利润为-21.41百万美元，同比增加29.66%；其中营业收入为96.67百万美元，同比增加23.86%，每股基本收益为-0.39美元。从资产负债表来看，Glaukos Corporation总负债2.58亿美元，其中短期债务0.00美元，资产负债比为3.60，流动比率为0.06。机构评级：截至2024年11月10日，当前有11家机构对Glaukos Corporation目标价做出预测，其中目标均价为139.82美元，其中最低目标价为115.00美元，最高目标价为155.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000429abb101b3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241110000429abb101b3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GKOS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.glaukos.com","stockEarnings":[{"period":"1week","weight":-0.1799},{"period":"1month","weight":-0.2539},{"period":"3month","weight":-0.4477},{"period":"6month","weight":-0.3614},{"period":"1year","weight":-0.1112},{"period":"ytd","weight":-0.4421}],"compareEarnings":[{"period":"1week","weight":-0.0907},{"period":"1month","weight":-0.1334},{"period":"3month","weight":-0.1464},{"period":"6month","weight":-0.1182},{"period":"1year","weight":-0.0152},{"period":"ytd","weight":-0.1379}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Glaukos Corporation于1998年7月14日在特拉华州注册成立。该公司是一家眼科制药和医疗技术公司，专注于开发新型无滴剂疗法，并将相关产品商业化，用于治疗青光眼、角膜疾病和视网膜疾病。他们首先开发了微创青光眼手术（MIGS）作为传统青光眼治疗模式的替代方案，并于2012年推出了他们的第一台MIGS设备。他们还提供商业化的专有生物激活药物疗法，用于治疗罕见的角膜疾病圆锥角膜，该疗法于2016年获得美国食品和药物管理局（FDA）的批准。他们正在开发一系列平台，以支持正在进行的制药和医疗器械创新。","yearOnYearQuotes":[{"month":1,"riseRate":0.9,"avgChangeRate":0.086384},{"month":2,"riseRate":0.6,"avgChangeRate":-0.00698},{"month":3,"riseRate":0.6,"avgChangeRate":-0.022683},{"month":4,"riseRate":0.5,"avgChangeRate":0.000182},{"month":5,"riseRate":0.555556,"avgChangeRate":0.027326},{"month":6,"riseRate":0.888889,"avgChangeRate":0.112367},{"month":7,"riseRate":0.7,"avgChangeRate":0.036945},{"month":8,"riseRate":0.4,"avgChangeRate":0.042947},{"month":9,"riseRate":0.4,"avgChangeRate":-0.020194},{"month":10,"riseRate":0.5,"avgChangeRate":-0.024992},{"month":11,"riseRate":0.5,"avgChangeRate":0.012839},{"month":12,"riseRate":0.5,"avgChangeRate":0.008639}],"exchange":"NYSE","name":"Glaukos Corp","nameEN":"Glaukos"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.32.1","shortVersion":"4.32.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Glaukos Corp(GKOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Glaukos Corp(GKOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Glaukos Corp,GKOS,Glaukos Corp股票,Glaukos Corp股票老虎,Glaukos Corp股票老虎国际,Glaukos Corp行情,Glaukos Corp股票行情,Glaukos Corp股价,Glaukos Corp股市,Glaukos Corp股票价格,Glaukos Corp股票交易,Glaukos Corp股票购买,Glaukos Corp股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Glaukos Corp(GKOS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Glaukos Corp(GKOS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}